analyzeportfolio
Nasdaq · Financials

Advanced Flower Capital Inc. (AFCG)

As-reported financials and SEC filings for Advanced Flower Capital Inc. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Advanced Flower Capital Inc.

Advanced Flower Capital Inc. is an institutional lender that specializes in originating, structuring, underwriting, investing in, and managing senior secured loans and other debt securities. The company primarily serves cannabis industry operators and ancillary businesses in states where cannabis is legal, as well as other middle-market companies. It provides financing solutions secured by real estate, equipment, cash flows, and license values, aiming to deliver risk-adjusted returns through cash distributions and capital appreciation.

Snapshot

Revenue
Revenue growth (YoY)
Net income
$-20.7M
Diluted EPS
$-0.95
Gross margin
Operating margin
Net margin
FCF margin
ROE
-11.8%
net income / fiscal-year-end equity
P/E
trailing when available, otherwise FY EPS
Market cap
$77.5M
Long-term debt / equity
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Advanced Flower Capital

  • Net income turned to a $21M loss in FY2025, from a $17M profit in FY2024.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Advanced Flower Capital’s fundamentals sit among the 51 business development companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

ROE-11.8%
15th percentile of 48
Short interest10.03d
98th percentile of 49

Advanced Flower Capital’s return on equity of -11.8% ranks in the 15th percentile of the 48 business development companies reporting it.

10 reported insider purchases (code P) totaling $663,330 in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among business development company peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 4 quant / multi-strat books among the superinvestors we track; no conviction manager currently reports a position.

Conviction investors
0
+4 quant / multi-strat
Initiated / added
1
0 new, 1 added
Reduced / exited
4
3 trimmed, 1 exited
Combined position
$1.1M
reported long value
InvestorAs ofPosition valueSharesChange
D. E. ShawquantQ2 2026$361,061116.5KAdded
Citadel AdvisorsquantQ2 2026$354,662114.4KReduced
Renaissance TechnologiesquantQ2 2026$208,01067.1KReduced
Millennium ManagementquantQ2 2026$134,78543.5KReduced

No longer held by: AQR Capital Management (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4. Multiple insiders have bought recently (a cluster buy).

Buys (90d)
10
3 insiders
Bought (90d)
$663K
code P value
Sells (90d)
0
Reported activity
Cluster buy
≥2 insiders buying
Trade dateInsiderTypeSharesPriceValue
2026-08-27
filed 2026-08-28
TANNENBAUM LEONARD MDirectorBuy15.2K$3.46$53K
2026-08-26
filed 2026-08-28
TANNENBAUM LEONARD MDirectorBuy19.4K$3.41$66K
2026-08-25
filed 2026-08-26
TANNENBAUM LEONARD MDirectorBuy30.0K$3.40$102K
2026-08-24
filed 2026-08-26
TANNENBAUM LEONARD MDirectorBuy30.0K$3.41$102K
2026-08-21
filed 2026-08-24
TANNENBAUM LEONARD MDirectorBuy25.0K$3.28$82K
2026-08-20
filed 2026-08-21
TANNENBAUM LEONARD MDirectorBuy20.0K$3.29$66K
2026-08-19
TANNENBAUM LEONARD MDirectorBuy12.8K$3.48$45K
2026-08-14
filed 2026-08-17
TANNENBAUM LEONARD MDirectorBuy45.8K$3.06$140K
2026-08-14
filed 2026-08-17
Hetzel BrandonCFO and TreasurerBuy1.5K$3.00$4K
2026-08-14
filed 2026-08-18
Tannenbaum RobynPresident and CIOBuy1.0K$3.15$3K
2026-05-14
filed 2026-05-19
TANNENBAUM LEONARD MDirectorBuy90.6K$2.84$257K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
808.3K
settled 2026-08-14
Change vs prior
-19.4%
vs previous settlement
Days to cover
10.03
at avg daily volume
Avg daily volume
80.6K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-14808.3K-19.4%10.03
2026-07-311.0M+9.3%12.99
2026-07-15918.3K-20.9%10.46
2026-06-301.2M+4.7%10.53
2026-06-151.1M+24.0%8.23
2026-05-29895.5K-12.6%3.54
2026-05-151.0M-20.6%2.11
2026-04-301.3M-9.2%8.59

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$24.6M$45.7M$63.9M$74.7M
Gross profit
Operating income
Net income$-20.7M$16.8M$21.0M$35.9M$21.0M
Diluted EPS$-0.95$0.78$1.02$1.79$1.52

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$38.6M$103.6M$90.4M$140.4M$109.2M
Current assets
Total assets$275.6M$402.1M$466.6M$519.2M$464.8M
Current liabilities
Long-term debt
Total liabilities$100.0M$200.7M$146.5M$180.1M$191.8M
Total equity$175.6M$201.4M$320.1M$339.1M$273.1M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$11.2M$21.6M$21.2M$31.3M$9.5M
Capital expenditure
Free cash flow

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$5.4M$0.23
Q1 FY2026$11.4M$0.49
Q4 FY2025$5.2M-32.1%$914,046$0.04
Q3 FY2025$6.5M-26.5%$-12.5M$-0.57
Q2 FY2025$6.2M-62.2%$-13.2M$-0.60
Q1 FY2025$6.6M-47.8%$4.1M$0.18
Q4 FY2024$7.6M-51.5%$-991,534$-0.05
Q3 FY2024$8.9M-41.8%$1.4M$0.06

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNasdaq
SectorFinancials
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2020
SEC CIK1822523

Selected SEC filings

10-K2026-03-04
View on EDGAR →
10-Q2026-08-13
View on EDGAR →
10-Q2026-05-07
View on EDGAR →
8-K2026-08-26
View on EDGAR →
8-K2026-08-13
View on EDGAR →
8-K2026-06-30
View on EDGAR →
8-K2026-06-18
View on EDGAR →

Largest Financials peers

All Financials companies →

Monitor AFCG

Get an alert when Advanced Flower Capital files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor AFCG free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.